StockpollyBeta
Get App
Popularity #4,577
IPHA · NASDAQ · Biotechnology

Innate Pharma (ADR) (IPHA)

Develops innate-immunity-based antibody therapies for cancer alongside AstraZeneca and Sanofi collaborations.

$1.76
vs last close−0.04 (−2.22%)

In millions of USD, except per-share figures · converted from EUR at the latest rate

In millionsQ4 FY20Dec 2020Q2 FY21Jun 2021Q4 FY21Dec 2021Q2 FY22Jun 2022Q4 FY22Dec 2022Q2 FY23Jun 2023Q4 FY23Dec 2023Q2 FY24Jun 2024Q4 FY24Dec 2024Q2 FY25Jun 2025Q4 FY25Dec 2025Q2 FY26Jun 2026
Revenue3111347940191406−24
Cost of revenue512151415182833−332300
Gross profit25−1−1233−622−4−1933−18210
433836404042101162115328
Research & development25232927293228332623260
18156131110101131119
Selling & marketing000000000000
General & administrative1877131110101131120
Other expenses000000−28−3333−232519
Operating income−20−30−355−33−6−8−30−29−29−32−25
−49−22−2−45232150−1
Interest income0000011430180
Interest expense000000310030
Other non-operating income492−20−19−300−3000
Income before tax−69−33−342−78−4−5−28−28−24−32−26
Income tax expense−8−6−9−5−4−60000−3−3
Net income from continuing operations−61−27−257−732−11−28−28−24−31−23
Discontinued operations00−8000000000
Other adjustments000000000000
Net income−61−27−337−732−11−28−28−24−31−23
EPS, basic−$0.77−$0.34−$0.42$0.09−$0.91$0.02−$0.14−$0.35−$0.34−$0.28−$0.34−$0.24
EPS, diluted−$0.77−$0.34−$0.42$0.09−$0.91$0.02−$0.14−$0.35−$0.34−$0.28−$0.34−$0.24
Weighted average shares, basic797980808080818081859194
Weighted average shares, diluted797980828084818181879194
EBITDA−61−30−317−111−12−29−24−29−35−24
Depreciation & amortization723234211011
EBIT−69−32−335−14−3−14−30−26−29−36−25